Head to Head Contrast: Daxor (NASDAQ:DXR) versus Titan Medical (NASDAQ:TMDIF)

Titan Medical (NASDAQ:TMDIF) and Daxor (NASDAQ:DXR) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability.

Valuation and Earnings

This table compares Titan Medical and Daxor”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Titan Medical	$17.63 million	3.23	$6.95 million	$0.05	10.00
Daxor	N/A	N/A	N/A	N/A	N/A

Titan Medical has higher revenue and earnings than Daxor.

Institutional & Insider Ownership

0.0% of Titan Medical shares are owned by institutional investors. Comparatively, 1.3% of Daxor shares are owned by institutional investors. 0.0% of Titan Medical shares are owned by insiders. Comparatively, 59.0% of Daxor shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Titan Medical and Daxor’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Titan Medical	N/A	-82.31%	-51.47%
Daxor	N/A	N/A	N/A

Risk & Volatility

Titan Medical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the S&P 500. Comparatively, Daxor has a beta of -0.51, suggesting that its stock price is 151% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of current ratings for Titan Medical and Daxor, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Titan Medical	0	0	0	0	0.00
Daxor	0	0	1	0	3.00

Daxor has a consensus target price of $24.75, suggesting a potential upside of 201.09%. Given Daxor’s stronger consensus rating and higher probable upside, analysts clearly believe Daxor is more favorable than Titan Medical.

Summary

Daxor beats Titan Medical on 7 of the 9 factors compared between the two stocks.

About Titan Medical

Titan Medical Inc. operates as a medical technology company. It focuses on the development and licensing of robotic assisted surgical technologies. The company is headquartered in Toronto, Canada.

About Daxor

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.